Exploratory Analysis of Brigatinib Activity in Patients With Anaplastic Lymphoma Kinase-Positive Non–Small-Cell Lung Cancer and Brain Metastases in Two Clinical Trials

Leggi l'articolo originale


Journal of Clinical Oncology, Ahead of Print.

Lascia un commento